Phytopharmaceuticals in India: A case for perpetual ‘New Drug’-style regulation over ASU-style liberalisation and counterproductive genericisation.

Read more

Express Pharma May 2026

Read more

Lilly supports Haryana State-FDA action against counterfeit medicines

Read more

SPARC to sell Rare Paediatric Disease Priority Review Voucher for $195 million

Read more

FDD Conclave 2026 | 5th June 2026

Read more

Parexel acquires Vitrana to expand pharmacovigilance technology platform

Read more

CDSCO West Zone to conduct webinar on WHO-GMP and COPP application process via ONDLS

Read more

Dr Reddy’s receives Health Canada approval for generic Semaglutide Injection

Read more

Express Pharma World Expo 2027

Read more

VESCOP, ENTOD and APTI Maharashtra host Vision 360 symposium on ophthalmic innovation

Read more